Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05365997 · ClinicalTrials.gov registry record · NA
Behavioral Nudges to Improve Palliative Care Utilization in Advanced Cancer
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 266
- Enrollment target
NCT05365997 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 266 participants.
The verdict
NCT05365997, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 266 participants
- Enrollment target
Study Summary
Patients with cancer often undergo costly therapy and acute care utilization that is discordant with their wishes, particularly at the end of life. Despite early palliative care consultations being a National Comprehensive Cancer Network (NCCN) guideline-concordant practice in advanced cancer, palliative care referral rates for stage IV patients are low. In this project, the investigators will evaluate a health system initiative that uses behavioral nudges to prompt palliative care referrals among outpatients with advanced cancer in terms of successful palliative care referrals and downstream quality of life outcomes. In partnership with the health system, this will be conducted as a 2-arm pragmatic cluster randomized trial.
Interventions
- OTHER Default Nudge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 266 participants |
| Start Date | 2022-05-23 |
| Est. Completion | 2023-08-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05365997
The ClinicalTrials.gov registry entry for NCT05365997 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 266 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Default Nudge is the first listed.
NCT05365997 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05365997 about?
NCT05365997 is a clinical study titled "Behavioral Nudges to Improve Palliative Care Utilization in Advanced Cancer". Patients with cancer often undergo costly therapy and acute care utilization that is discordant with their wishes, particularly at the end of life. Despite early palliative care consultations being a National Comprehensive Cancer Network (NCCN) guideline-concordant practice in advanced cancer, palli...
What is the current status of trial NCT05365997?
This trial is currently completed. It is a NA study. The enrollment target is 266 participants. The study started on 2022-05-23. Estimated completion is 2023-08-08.
What interventions are being tested in trial NCT05365997?
The interventions under investigation include: Default Nudge (OTHER).
Who is sponsoring clinical trial NCT05365997?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.